Reading time: 5 minutes Sandhyaa Venkatachalam Who doesn’t love dark chocolate? A moment of pure bliss in every square… a deep, complex flavor in every bite… a luxurious treat that dances between bitter and sweet… dark chocolate is a true celebration of indulgence. What’s more tempting is the abundant dose of health benefits that dark... Continue Reading →
The Path Toward a CRISPR Picture of BRCA Gene Variants
Reading time: 5 minutes Anthony Tao According to the National Breast Cancer Foundation, 1 in 8 women will have breast cancer in their lifetime. In 2024, an estimated 300,000 women and nearly 3000 men were diagnosed with breast cancer.1,2 In many cases, breast cancer can be attributed to two genes ‒ BRCA1 and BRCA2 (collectively... Continue Reading →
From Pixels to Prognosis: The Role of Radiomics in Oncology
Reading time: 5 minutes Preeti Prangya Panda In 1895, Wilhelm Roentgen discovered X-rays that paved the way for seeing into the human body. This invention revolutionized medical science. Today, the discovery has transformed into a powerful decoding tool that translates the hidden images in clinical scans. This emerging field is called radiomics, which is cracking... Continue Reading →
Under the brain tumor spell
Reading time: 5 minutes Mariella Careaga Glioblastoma is a highly aggressive form of cancer that accounts for nearly half of all primary malignant brain tumors in adults (1). Patients diagnosed with this deadly brain cancer have an average survival rate of only 8 months, and it is estimated that glioblastoma claims the lives of more... Continue Reading →
Double Trouble for Cancer: The Rise of Bispecific Antibodies
Reading time: 5 minutes Dolores Mruk, PhD Cancer treatments have come a long way since the early 1900s, evolving from chemotherapy and radiotherapy to more targeted interventions. One promising approach involves the use of bispecific antibodies (bsAbs)—engineered molecules that help in fighting cancer. Today, these immunotherapies are being studied across different malignancies, with a particular... Continue Reading →
Can overstimulation of oncogenic signaling of cancer cells be a potential therapeutic strategy?
Reading time: 6 minutes Colin Ong Oncogenic signaling is a key characteristic of cancer cells Cancer cells, unlike normal cells, exhibit aberrant oncogenic signaling. This aberrant signaling, which is continuously turned on, facilitates the survival and proliferation of cancer cells as well as other hallmarks of cancer1. The term “oncogenic”, an adjective derived from the... Continue Reading →
Advancing CAR-T Cell Therapy: New Innovations in Outpatient Administration and Management
Reading time: 6 minutes Nicole Bowens Recent advancements within the past decade are making cancer treatments more effective and accessible, revolutionizing the way care is delivered and offering renewed hope to patients. These advancements have been made possible in part by personalized therapies that are tailored for individual patients. In one newly developed personalized therapy,... Continue Reading →
To sync or not to sync: Cancer’s complicated relationship with our internal clocks
Reading time: 5 minutes Andrea Lius For several decades, scientists have observed that disruptions to the body’s internal clock, also known as the circadian rhythm, can promote cancer development and progression.1 They also found that many fast-growing cancers have circadian rhythms that are desynchronized from healthy cells. However, glioblastoma (GBM), a deadly and aggressive type... Continue Reading →
The Obesity Paradox
Reading time: 8 minutes Nicholas A. Egan Obesity is a rising global health epidemic, with the number of obese adults doubling since the 1990s and the number of adolescents living with obesity quadrupling. This amounts to one in every eight people in the world living with obesity. Obesity comes with myriad other health issues. Specifically,... Continue Reading →
Newly approved combination treatment available for solid tumors!
Reading time: 6 minutes Brittane L. Strahan MSN, RN, CCRP The treatment of solid tumors is evolving constantly and rapidly in the vast oncology clinical research landscape. Though huge strides have been made in the treatment of even difficult tumor types (such as small cell lung cancer), there is still much work left to do.... Continue Reading →
Metastatic Colorectal Cancer with BRAF V600E Mutation Gains New FDA Approval
Reading time: 4 minutes Aishat Motolani Cetuximab, Panitumumab, Tucatinib, and Ipilimumab, just to name a few, are examples of drugs approved for metastatic colorectal cancer (mCRC) over the past two decades. However, due to the poor outcomes of some of these drugs in mCRC patients, researchers are exploring new treatment combinations to optimize efficacy. This... Continue Reading →
Vorasidenib: A case study in bench-to-bedside translational research
Reading time: 6 minutes Spencer Maingi Identifying IDH mutations and their function In 2008, researchers studying brain tumors discovered something surprising. Patients with “secondary glioblastoma”, a uniformly lethal cancer that arises from a prior, less aggressive brain tumor (“low-grade glioma”), frequently had mutations in their tumor in the gene isocitrate dehydrogenase 1 (IDH1).1 Even more... Continue Reading →
Hepatic Arterial Infusion Chemotherapy
Reading Time: 4 minutes Chris Wang The liver is a uniquely important organ in your body. It filters all of your blood, produces bile to digest foods/carry away waste, and can even regenerate even after 90% has been removed. Unfortunately, the liver is also an organ where many cancers metastasize to. Colorectal cancer in particular... Continue Reading →
Disparities in Cancer Care: A Closer Look at Incarcerated Populations
Reading time: 3 minutes Maya Razmi Cancer is one of the leading causes of death worldwide - in 2022, there were about 20 million new cases of cancer and 9.7 million cancer-related deaths. Though some individuals have access to treatment, many may not be so fortunate. Vulnerable populations are particularly susceptible to cancer, as they... Continue Reading →
Promising trials: Lorlatinib for NSCLC
Reading time: 4 minutes Karli Norville In 2021, lung cancer was ranked as the number one cause of cancer deaths in the United States (1). The American Cancer Society reports that the 5-year survival rate of all Non-Small Cell Lung Cancer (NSCLC) patients is 26% (2). A recent study of the cancer drug Lorlatinib announced... Continue Reading →
Bugs as drugs: Bacteria as a method of cancer vaccination
Reading time: 6 minutes Anthony Tao Smallpox was once a devastating disease, speculated to have incited numerous plagues throughout history including the Plague of Athens in 430 BC and the epidemic that decimated the Aztec population of the once great city of Tenochtitlan in 1520. In the 18th century, 400,000 deaths a year were attributed... Continue Reading →
Glioblastoma: 100 Years of Failure
Reading time: 7 minutes Shan Grewal Glioblastoma multiforme (GBM) is one of the worst diagnoses a patient can receive today. The median survival of this cancer is just under 15 months, meaning half of patients with GBM will pass away within 1.5 years. Only 4% of patients reach the 5-year mark.1 GBM has left an... Continue Reading →
Integrating Mental Health into Oncology: Assessing Depression Among Cancer Patients Using the Beck Depression Inventory-II
Reading time: 3 minutes Maya Razmi Understanding depression in cancer patients is crucial for holistic care. This study highlights the prevalence of depression using the Beck Depression Inventory-II, emphasizing the need for integrated mental health support in oncology. Oftentimes, when we think of oncology research, we think of novel diagnostics and therapeutics. However, cancer is... Continue Reading →
Uncovering how chronic stress induces metastasis
Reading time: 8 minutes Colin Ong For most of us, stress is an inevitable facet of life. Any internal or external stimulus such as encountering a bear while hiking will trigger stress in our bodies. Remarkably, our bodies respond through a series of orchestrated biochemical and physiological changes as a way of coping with stress.... Continue Reading →
The Stress-Cancer Connection: Fact or Fiction?
Reading time: 5 minutes Hema Saranya Ilamathi It’s Monday morning! The alarm goes off, and your mind immediately floods with thoughts: meetings with the boss, deadlines to meet, the week’s workload, and the rush to get to work on time. The stress is already kicking in—sound familiar?. In a competitive and fast-paced world, stress has... Continue Reading →
A sun-sational study on vitamin D and cancer
Reading time: 4 minutes Anthony Tao Sunny weather can make the difference between a bleak and mundane work day versus a day filled with joy and festivity. People generally feel better when the sun's out. Foods taste better, music sounds livelier, and the air feels more hopeful. And the need for hope is perhaps most... Continue Reading →
Talk to Your Doctor: Shared Decision Making in Cancer Therapy
Reading time: 5 minutes Sara Musetti Jenkins, PhD Being diagnosed with cancer is one of the scariest things to ever happen to many people. Regardless of whether it comes suddenly and without warning or after waiting, agonizingly, for test results, it is nearly impossible to prepare for the way it impacts you. Many patients find... Continue Reading →
From Algorithms to Articles: AI in Scientific and Medical Writing and Application
Reading time: 5 minutes Keighley Reisenauer, Ph.D Chat Generative Pre‐trained Transformer (ChatGPT; OpenAI, San Francisco, CA) and other artificial intelligence (AI)-based generative software have taken hold within social media and creative spheres, to both the delight and annoyance of the users within those spaces. Initially, outputs were flawed or, in some cases, completely incorrect, leading... Continue Reading →
TEAMWORK MAKES THE DREAM WORK: COMBINING CAR-T AND CRISPR/CAS9 TO TREAT CANCER?
Reading time: 5 minutes Yousra Iftequar You know what they say, “It takes two flints to make a fire.” Researchers have exactly put that into action and have made an effort to combine these two revolutionary techniques. WHAT IS CAR T-CELL IMMUNOTHERAPY? Immunotherapy utilizing the body's immune system has emerged as a promising new approach... Continue Reading →
Reasons for Increased Prevalence of Early-Onset Colorectal Cancer
Reading time: 3 minutes Colette Bilynsky A significant portion of my PhD research was related to colorectal cancer (CRC), so I had seen in the academic literature that the incidence rate of CRC was increasing for people under 50 years of age. Despite this, I was still surprised when on my social media I started... Continue Reading →
Putting a Backpack on Cells to Treat Cancer
Reading time: 4 minutes Colette Bilynsky The wonders of cellular therapies and immunotherapies have been often discussed here on Oncobites. But one of the challenges here is that these strategies are dependent on immune cells' ability to reach tumors and still function. However, tumors will often try to evade and stop the immune system from... Continue Reading →
Neural Networks in Neurosurgery: The Role of AI as a Surgical Assistant
Reading time: 5 minutes Anthony Tao The modern computer has become a powerful part of society's infrastructure. Among millions of other things, computers are critical for facilitating financial services, research, communications, and politics. However, we can all perhaps agree that one of their LEAST important functions is the ability to recognize cats. However, in 2012,... Continue Reading →
The Balancing Act of Immune Checkpoint Inhibitors: Immune-related Adverse Events
Reading time: 5 minutes Karli Norville Immune checkpoint inhibitors (ICIs) have been so impactful in the treatment of cancer in recent years that the basic research supporting their development was the subject of the 2018 Nobel Prize in Physiology or Medicine (1). Despite their clinical success, the occurrence of immune-related adverse events (irAEs) within a... Continue Reading →
M1 Kills, M2 Heals: The Effects of Different Subsets of Macrophages in Cancer
Reading time: 7 minutes Gracie Jennah Mead Introduction Macrophages are an important part of the innate immune system. Within the innate immune system, which comprises more indiscriminate strategies that protect us from pathogens in general, macrophages engulf and break down pathogens. Macrophages are a diverse cell as they can regulate tissue development and tissue repair... Continue Reading →
Antibiotics in Cancer Treatment: Unraveling the Unseen Risks
Reading time: 3 minutes Yonika Larasati Since the advent of antibiotics more than one century ago, this class of drugs has tremendously changed humanity. In addition to treating bacteria-caused infectious diseases, antibiotics enable modern medical procedures, such as open-heart surgery and organ transplantation. Antibiotics are also essential for cancer patients. Cancer patients often face an... Continue Reading →
